SCHEMBL7695317

SCHEMBL7695317

Clc1ccc(Cl)c(SCc2nc3cc4ccccc4cc3nc2CSc2cc(Cl)ccc2Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.39
LMNA P02545 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
NQO2 P16083 1/20 0.36
ALDH1A1 P00352 2/20 0.36
THRB P10828 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
CYP2D6 P10635 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.34
MAPT P10636 2/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7697058 0.86 RAB9A (0.50) LMNASMN1; SMN2NPC1RAB9ANQO2
SCHEMBL7697719 0.80 NPC1 (0.50) SMN1; SMN2NPC1RAB9ACYP1A2CYP2C9
SCHEMBL7695424 0.77 CYP1A2 (0.42) LMNANPC1RAB9ACYP1A2CYP3A4
SCHEMBL7697050 0.77 TDP1 (0.44) CYP2A6LMNACYP1A2CYP3A4CYP2C9
SCHEMBL7698500 0.76 SOD1 (0.44) CYP2A6LMNASMN1; SMN2NPC1RAB9A
SCHEMBL7694614 0.73 HTR7 (0.40) CYP2A6LMNASMN1; SMN2NPC1RAB9A
SCHEMBL7698454 0.72 NQO2 (0.45) LMNASMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL7696122 0.71 HPGD (0.43) CYP2A6LMNASMN1; SMN2NPC1RAB9A
SCHEMBL7692496 0.70 SMN1; SMN2 (0.40) CYP2A6LMNASMN1; SMN2CYP1A2CYP2C19
SCHEMBL7697768 0.70 SMN1; SMN2 (0.50) LMNASMN1; SMN2NPC1RAB9ANQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002094796-A2 BENZO[G]QUINOXALINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST INFECTIOUS DISEASES AXXIMA PHARMACEUTICALS AG (DE) 2002-11-28 WO disclosed